-
Pharmacology
-
- Enzymes
-
- ATPase & GTPase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Isomerase
- Kinase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- - Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 548 products in: Biochemicals >> Research Area >> Pain & inflammation
Pain & inflammation beginning with A - C |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| Broad spectrum nucleoside antibiotic Purity: > 98% |   | ||
| Potent, selective, inhibitor of myosin II Purity: > 98% |   | ||
| Selective myosin II ATPase activity inhibitor Purity: > 99% | | ||
| Potent Cdk5/p25 and Cdk2 inhibitor Purity: > 98% | | ||
| Potent, selective ETA receptor antagonist Purity: > 95% | | ||
| Bradykinin receptor agonist Purity: > 98% | | ||
| Inihibitor of ADP-ribosylation factor Purity: > 99% | | ||
| Highly selective, potent κ-opioid agonist Purity: > 99% | | ||
| Positive allosteric modulator at M1 receptors. Purity: > 98% | | ||
| Non-selective myosin ATPase inhibitor | | ||
| Non-physiological and biologically active ceramide analog. Purity: > 98% | | ||
| Specific NF-κB inhibitor Purity: > 98% | | ||
| Cell-permeable dye for determining cell viability Purity: > 95% | | ||
| Most active form of vitamin D Purity: > 99% | | ||
| Potent irreversible EGFR and HER2/ErbB2 tyrosine kinase inhibitor Purity: > 99% | | ||
| Common constituent of Cannabis Purity: > 98% | | ||
| VR1 antagonist Purity: > 99% | | ||
| Anti-cancer, anti-inflammatory spice-derived chalcone analog Purity: > 98% | | ||
| Potent PI3Kγ and casein kinase 2 inhibitor Purity: > 98% | | ||
| CK2 inhibitor Purity: > 95% | | ||
| Selective, ATP competitive CK2 inhibitor Purity: > 95% | | ||
| C-terminal ocatapeptide of CCK Purity: > 95% | | ||
| PAM for mGlu5. Active in vivo. Purity: > 98% | | ||
| Anti-inflammatory and anti-proliferative agent Purity: > 99% | | ||
| Fluorescent GABAB antagonist Purity: > 97% | | ||
| GABAB antagonist, brain penetrant | | ||
| Na+-Ca2+ exchange inhibitor Purity: > 99% | | ||
| Competitive NMDA antagonist Purity: > 99% | | ||
| Competitive NMDA antagonist Purity: > 99% | | ||
| Potent GABAB antagonist Purity: > 99% | | ||
| Potent, selective GABAB antagonist Purity: > 98% | | ||
| Positive GABAB receptor allosteric modulator Purity: > 98% | | ||
| K+ channel blocker Purity: > 98% | | ||
| Apoptosis inducer. Protein kinase C inhibitor. Purity: > 99% | | ||
| Potent, highly selective GSK3 inhibitor Purity: > 98% | | ||
| Broad spectrum anti-microbial agent Purity: > 98% | | ||
| Antioxidant with a variety of biological effects Purity: > 99% | | ||
| NMDA receptor glycine site antagonist Purity: > 99% | | ||
| NMDA receptor glycine site antagonist; water soluble Purity: > 99% | | ||
| 8-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate (8-CPT-cAMP) | Cell permeable cAMP analogue, protein kinase modulator Purity: > 98% | | |
| AMPA / kainate agonist Purity: > 98% | | ||
| Potent H1 antagonist and SNRI Purity: > 99% | | ||
| Typical antipsychotic. Non-selective receptor antagonist. Purity: > 99% | | ||
| Selective mGlu5 agonist Purity: > 98% | | ||
| mGlu5 agonist; water soluble Purity: > 99% | | ||
| Antioxidant flavonoid; potent anti-inflammatory effects Purity: > 99% | | ||
| Prototypic H2 antagonist. I1 agonist. Purity: > 99% | | ||
| 5-HT4 receptor agonist. hERG blocker. Purity: > 99% | | ||
| Potent inhibitor of actin polymerization Purity: > 99% | | ||
| Macrolide antibiotic Purity: > 98% | | ||
| Metal chelator and ionophore Purity: > 97% | | ||
| Fluorescent H3 antagonist Purity: > 97% | | ||
| Selective H3 antagonist Purity: > 99% | | ||
| Selective estrogen receptor modulator (SERM) Purity: > 98% | | ||
| Metabolite of Clozapine Purity: > 99% | | ||
| AMPA / kainate antagonist Purity: > 99% | | ||
| AMPA / kainate antagonist (water soluble) Purity: > 99% | | ||
| Inhibitor of microtubule formation Purity: > 99% | | ||
| Potent inhibitor of tubulin polymerization Purity: > 98% | | ||
| Ca2+ channel blocker (N type) Purity: > 96% | | ||
| Ca2+ channel blocker (P and Q-type) Purity: > 95% | | ||
| Nucleoside antagonist. Inhibits NF-κB signaling Purity: > 98% | | ||
| Selective, non-competitive mGlu1 antagonist Purity: > 98% | | ||
| Potent NMDA antagonist | | ||
| Potent NMDA antagonist | | ||
| Potent competitive NMDA antagonist Purity: > 98% | | ||
| Potent group II/III metabotropic glutamate receptor antagonist Purity: > 99% | | ||
| KIR6.x (KATP) channel activator Purity: > 99% | | ||
| STAT3 inhibitor with diverse biological activities Purity: > 99% | | ||
| Potent, selective μ opioid antagonist Purity: > 95% | | ||
| Potent, selective μ opioid receptor antagonist. Purity: > 95% | | ||
| Flavonoid. Lipooxygenase inhibitor. Anti-oxidant, anti-inflammatory agent. Purity: > 85% | | ||
| Protein synthesis inhibitor Purity: > 98% | | ||
| Hh signaling inhibitor Purity: > 97% | | ||
| Alkylating agent; chemotherapeutic Purity: > 99% | |